Literature DB >> 18794282

Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine.

Rafael D Mesquita1, Alan Brito Carneiro, André Bafica, Felipe Gazos-Lopes, Christina M Takiya, Thaís Souto-Padron, Danielle P Vieira, Antônio Ferreira-Pereira, Igor C Almeida, Rodrigo T Figueiredo, Bárbara N Porto, Marcelo T Bozza, Aurélio V Graça-Souza, Angela H C S Lopes, Geórgia C Atella, Mário A C Silva-Neto.   

Abstract

Trypanosoma cruzi, the etiological agent of Chagas disease, is transmitted by bug feces deposited on human skin during a blood meal. However, parasite infection occurs through the wound produced by insect mouthparts. Saliva of the Triatominae bug Rhodnius prolixus is a source of lysophosphatidylcholine (LPC). Here, we tested the role of both triatomine saliva and LPC on parasite transmission. We show that vector saliva is a powerful inducer of cell chemotaxis. A massive number of inflammatory cells were found at the sites where LPC or saliva was inoculated into the skin of mice. LPC is a known chemoattractant for monocytes, but neutrophil recruitment induced by saliva is LPC independent. The preincubation of peritoneal macrophages with saliva or LPC increased fivefold the association of T. cruzi with these cells. Moreover, saliva and LPC block nitric oxide production by T. cruzi-exposed macrophages. The injection of saliva or LPC into mouse skin in the presence of the parasite induces an up-to-sixfold increase in blood parasitemia. Together, our data suggest that saliva of the Triatominae enhances T. cruzi transmission and that some of its biological effects are attributed to LPC. This is a demonstration that a vector-derived lysophospholipid may act as an enhancing factor of Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794282      PMCID: PMC2583594          DOI: 10.1128/IAI.00683-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes.

Authors:  A K Ryborg; B Deleuran; H Søgaard; K Kragballe
Journal:  Acta Derm Venereol       Date:  2000 Jul-Aug       Impact factor: 4.437

2.  Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages.

Authors:  T Ogita; Y Tanaka; T Nakaoka; R Matsuoka; Y Kira; M Nakamura; T Shimizu; T Fujita
Journal:  Am J Physiol       Date:  1997-01

3.  Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents.

Authors:  I C Almeida; M M Camargo; D O Procópio; L S Silva; A Mehlert; L R Travassos; R T Gazzinelli; M A Ferguson
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

Review 4.  The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections.

Authors:  S Kamhawi
Journal:  Microbes Infect       Date:  2000-11       Impact factor: 2.700

Review 5.  The development of Trypanosoma cruzi in triatominae.

Authors:  A H Kollien; G A Schaub
Journal:  Parasitol Today       Date:  2000-09

Review 6.  Immune system recognition of Trypanosoma cruzi.

Authors:  Rick L Tarleton
Journal:  Curr Opin Immunol       Date:  2007-07-24       Impact factor: 7.486

7.  Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva.

Authors:  Anderson Sá-Nunes; André Bafica; David A Lucas; Thomas P Conrads; Timothy D Veenstra; John F Andersen; Thomas N Mather; José M C Ribeiro; Ivo M B Francischetti
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

8.  Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors.

Authors:  Bárbara N Porto; Letícia S Alves; Patricia L Fernández; Tatiana P Dutra; Rodrigo T Figueiredo; Aurélio V Graça-Souza; Marcelo T Bozza
Journal:  J Biol Chem       Date:  2007-06-20       Impact factor: 5.157

9.  Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.

Authors:  Anthony W Ashton; Shankar Mukherjee; F N U Nagajyothi; Huan Huang; Vicki L Braunstein; Mahalia S Desruisseaux; Stephen M Factor; Lillie Lopez; Joan W Berman; Murray Wittner; Philipp E Scherer; Valerie Capra; Thomas M Coffman; Charles N Serhan; Katherine Gotlinger; Kenneth K Wu; Louis M Weiss; Herbert B Tanowitz
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

10.  Leishmania manipulation of sand fly feeding behavior results in enhanced transmission.

Authors:  Matthew E Rogers; Paul A Bates
Journal:  PLoS Pathog       Date:  2007-06       Impact factor: 6.823

View more
  27 in total

1.  Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.

Authors:  R Parra Millán; M E Jiménez Mejías; V Sánchez Encinales; R Ayerbe Algaba; A Gutiérrez Valencia; M E Pachón Ibáñez; C Díaz; J Pérez Del Palacio; L F López Cortés; J Pachón; Y Smani
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Heterogeneous infectiousness in guinea pigs experimentally infected with Trypanosoma cruzi.

Authors:  Ricardo Castillo-Neyra; Katty Borrini Mayorí; Renzo Salazar Sánchez; Jenny Ancca Suarez; Sherrie Xie; Cesar Náquira Velarde; Michael Z Levy
Journal:  Parasitol Int       Date:  2015-10-22       Impact factor: 2.230

3.  Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii.

Authors:  Younes Smani; Juan Domínguez-Herrera; José Ibáñez-Martínez; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

Review 4.  Vaccines to combat the neglected tropical diseases.

Authors:  Jeffrey M Bethony; Rhea N Cole; Xiaoti Guo; Shaden Kamhawi; Marshall W Lightowlers; Alex Loukas; William Petri; Steven Reed; Jesus G Valenzuela; Peter J Hotez
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus.

Authors:  Luciana T Zimmermann; Evelize Folly; Marta T Gomes; Daniela S Alviano; Celuta S Alviano; Fernando C Silva-Filho; Geórgia C Atella; Angela H Lopes
Journal:  Parasitol Res       Date:  2010-12-14       Impact factor: 2.289

6.  Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic Plasmodium falciparum infections and correlation with IgE and IgG titers.

Authors:  Ramatoulaye Lawaly; Lassana Konate; Laurence Marrama; Ibrahima Dia; Diawo Diallo; Fatoumata Diène Sarr; Bradley S Schneider; Isabelle Casademont; Mawlouth Diallo; Paul T Brey; Anavaj Sakuntabhai; Salah Mecheri; Richard Paul
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

7.  Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine.

Authors:  Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Inflamm Res       Date:  2012-01-18       Impact factor: 4.575

8.  Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.

Authors:  Noah W Palm; Rachel K Rosenstein; Shuang Yu; Dominik D Schenten; Esther Florsheim; Ruslan Medzhitov
Journal:  Immunity       Date:  2013-10-24       Impact factor: 31.745

9.  Lysophosphatidylcholine triggers cell differentiation in the protozoan parasite Herpetomonas samuelpessoai through the CK2 pathway.

Authors:  Fernando L Dutra; Danielle P Vieira; Felipe S Coelho; Camila M Adade; Geórgia C Atella; Mário A C Silva Neto; Angela H Lopes
Journal:  Acta Parasitol       Date:  2019-10-22       Impact factor: 1.440

10.  Vector saliva controlled inflammatory response of the host may represent the Achilles heel during pathogen transmission.

Authors:  Claudia Demarta-Gatsi; Salah Mécheri
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.